Literature DB >> 30072086

Rabies Virus.

Kirstyn Brunker1, Nardus Mollentze2.   

Abstract

This infographic describes the transmission cycle of rabies virus in domestic dogs and the necessity of a One Health approach, integrating medical and veterinary interventions, to control and eliminate human rabies deaths. Rabies virus (RABV) causes an acute, fatal neurological infection in humans and other mammals, transmitted through the saliva of rabid animals via a bite or scratch. From the site of infection the virus travels along neurons to the central nervous system (CNS), where viral replication leads to symptoms and systemic spread. Once symptomatic, the disease is nearly 100% fatal. However, the disease is 100% vaccine-preventable through the prompt administration of human postexposure prophylaxis (PEP) and vaccination of animal reservoirs. While RABV has a broad host range, domestic dogs cause over 99% of all human cases, killing 59000 people every year. Human PEP is costly (US$11-150 per dose) and often difficult to obtain. Dog vaccination is a considerably more cost-effective and feasible method to reduce the incidence of human rabies. With this in mind, the World Health Organisation (WHO) and partners have set a target for the global elimination of dog-mediated human rabies, through control of the disease in dogs, by 2030. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30072086     DOI: 10.1016/j.tim.2018.07.001

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  11 in total

1.  A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis.

Authors:  Monir Ejemel; Todd G Smith; Lauren Greenberg; William C Carson; David Lowe; Yong Yang; Felix R Jackson; Clint N Morgan; Brock E Martin; Chantal Kling; Christina L Hutson; Nadia Gallardo-Romero; James A Ellison; Susan Moore; Adam Buzby; John Sullivan-Bolyai; Mark Klempner; Yang Wang
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis.

Authors:  Grace S Hwang; Elsie Rizk; Lan N Bui; Tomona Iso; Emily I Sartain; Anh Thu Tran; Joshua T Swan
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

3.  Proteomic Profiling of Purified Rabies Virus Particles.

Authors:  Yan Zhang; Yuyang Wang; Ye Feng; Zhongzhong Tu; Zhiyong Lou; Changchun Tu
Journal:  Virol Sin       Date:  2019-08-19       Impact factor: 4.327

Review 4.  Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.

Authors:  Kostlend Mara; Meiling Dai; Aaron M Brice; Marina R Alexander; Leon Tribolet; Daniel S Layton; Andrew G D Bean
Journal:  Vaccines (Basel)       Date:  2021-01-17

5.  The Role of Waste Management in Control of Rabies: A Neglected Issue.

Authors:  Nicolette Wright; Deepak Subedi; Saurav Pantha; Krishna Prasad Acharya; Louis Hendrik Nel
Journal:  Viruses       Date:  2021-02-01       Impact factor: 5.048

Review 6.  On the Use of Phylogeographic Inference to Infer the Dispersal History of Rabies Virus: A Review Study.

Authors:  Kanika D Nahata; Nena Bollen; Mandev S Gill; Maylis Layan; Hervé Bourhy; Simon Dellicour; Guy Baele
Journal:  Viruses       Date:  2021-08-17       Impact factor: 5.048

7.  Knowledge, attitude, and practices associated with rabies in villages with different dog vaccination statuses in Cambodia.

Authors:  Bunsong Ung; Ketsarin Kamyingkird; Waraphon Phimpraphai
Journal:  Vet World       Date:  2021-08-24

8.  Incidence, Trend, and Mortality of Human Exposure to Rabies in Yemen, 2011-2017: Observational Study.

Authors:  Rihana Taher Abdulmoghni; Ahmed Hasan Al-Ward; Khaled Abdullah Al-Moayed; Mohammed Abdullah Al-Amad; Yousef S Khader
Journal:  JMIR Public Health Surveill       Date:  2021-06-22

Review 9.  Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.

Authors:  Wenshu He; Can Baysal; Maria Lobato Gómez; Xin Huang; Derry Alvarez; Changfu Zhu; Victoria Armario-Najera; Aamaya Blanco Perera; Pedro Cerda Bennaser; Andrea Saba-Mayoral; Guillermo Sobrino-Mengual; Ashwin Vargheese; Rita Abranches; Isabel Alexandra Abreu; Shanmugaraj Balamurugan; Ralph Bock; Johannes F Buyel; Nicolau B da Cunha; Henry Daniell; Roland Faller; André Folgado; Iyappan Gowtham; Suvi T Häkkinen; Shashi Kumar; Ramalingam Sathish Kumar; Cristiano Lacorte; George P Lomonossoff; Ines M Luís; Julian K-C Ma; Karen A McDonald; Andre Murad; Somen Nandi; Barry O'Keef; Subramanian Parthiban; Mathew J Paul; Daniel Ponndorf; Elibio Rech; Julio C M Rodrigues; Stephanie Ruf; Stefan Schillberg; Jennifer Schwestka; Priya S Shah; Rahul Singh; Eva Stoger; Richard M Twyman; Inchakalody P Varghese; Giovanni R Vianna; Gina Webster; Ruud H P Wilbers; Paul Christou; Kirsi-Marja Oksman-Caldentey; Teresa Capell
Journal:  Plant Biotechnol J       Date:  2021-07-19       Impact factor: 13.263

10.  Rapid in-country sequencing of whole virus genomes to inform rabies elimination programmes.

Authors:  Kirstyn Brunker; Gurdeep Jaswant; S M Thumbi; Kennedy Lushasi; Ahmed Lugelo; Anna M Czupryna; Fred Ade; Gati Wambura; Veronicah Chuchu; Rachel Steenson; Chanasa Ngeleja; Criselda Bautista; Daria L Manalo; Ma Ricci R Gomez; Maria Yna Joyce V Chu; Mary Elizabeth Miranda; Maya Kamat; Kristyna Rysava; Jason Espineda; Eva Angelica V Silo; Ariane Mae Aringo; Rona P Bernales; Florencio F Adonay; Michael J Tildesley; Denise A Marston; Daisy L Jennings; Anthony R Fooks; Wenlong Zhu; Luke W Meredith; Sarah C Hill; Radoslaw Poplawski; Robert J Gifford; Joshua B Singer; Mathew Maturi; Athman Mwatondo; Roman Biek; Katie Hampson
Journal:  Wellcome Open Res       Date:  2020-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.